Outcomes of Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Anal Cancer in Immunocompetent Versus Immunodeficient Patients
- 1 September 2009
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 75 (1), 143-149
- https://doi.org/10.1016/j.ijrobp.2008.10.046
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- HIV-Specific Differences in Outcome of Squamous Cell Carcinoma of the Anal Canal: A Multicentric Cohort Study of HIV-Positive Patients Receiving Highly Active Antiretroviral TherapyJournal of Clinical Oncology, 2008
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal CanalJama-Journal Of The American Medical Association, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Anal Cancer: Current and Future MethodologyCancer Investigation, 2006
- A Population-Based Analysis of Temporal Trends in the Incidence of Squamous Anal Canal Cancer in Relation to the HIV EpidemicJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral TherapyJNCI Journal of the National Cancer Institute, 2005
- Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency SyndromeJNCI Journal of the National Cancer Institute, 2000
- Carcinoma of the Anal CanalNew England Journal of Medicine, 2000
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.Journal of Clinical Oncology, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996